SCHEMBL7654658

SCHEMBL7654658

Cc1cc(O)c(C(=O)C=CC2=COC(Cc3ccccc3)O2)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.39
MAPT P10636 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
GUSB P08236 1/20 0.38
NFE2L2 Q16236 1/20 0.38
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
RECQL P46063 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664261 0.92 AR (0.39) APPMAPTALDH1A1KDM4EMEN1
SCHEMBL7664550 0.89 MAPT (0.43) MAPTALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL7666636 0.84 AR (0.58) MAPTALDH1A1KDM4EMEN1MAPK1
SCHEMBL7666145 0.84 MAOB (0.58) MAPTALDH1A1TDP1GUSBL3MBTL1
SCHEMBL7657806 0.84 AR (0.51) MAPTALDH1A1KDM4EMEN1THRB
SCHEMBL7652711 0.83 ABCG2 (0.60) APPMAPTALDH1A1MEN1CYP3A4
SCHEMBL7662659 0.83 MAPT (0.50) APPMAPTALDH1A1KDM4EMEN1
SCHEMBL7658891 0.82 NPC1 (0.40) MAPTALDH1A1MEN1HPGDMAPK1
SCHEMBL7654846 0.80 KDM4E (0.50) MAPTKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL7664988 0.80 AR (0.52) MAPTALDH1A1KDM4EMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US disclosed
EP-1109800-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LIMITED (KR) 2001-06-27 EP disclosed
WO-2000012496-A1 NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE LG CHEMICAL LTD. (KR) 2000-03-09 WO disclosed